Viroblock SA

28.10.2011 – 12:07
Viroblock closes Series C financing round
Plan-les-Ouates, Switzerland (ots) - Viroblock S.A., a company with a highly innovative, broadly applicable anti-viral air filtration technology, initially focused on development and commercialization of anti-viral face-masks, today announced the successful closure of a 3.3 million CHF Series C financing round. Dr Jamie Paterson, CEO of Viroblock, said "these funds allow Viroblock to complete the development of our ...
mehr
20.07.2007 – 09:30
Viroblock SA receives First Round of Equity Funding
Plan-les-Ouates (ots) - Viroblock SA, a start-up dedicated to developing and commercializing a new generation of antiviral products, today announced that it has completed its first round of equity funding led by private investor Peter Pfister, Fongit Seed Invest SA, and Initiative Capital Romandie SA. Viroblock also announced that the newly appointed Board of Directors will consist of Peter Pfister (Chairman), ...
mehr